Urinary excretion of epidermal-type fatty acid-binding protein and S100A7 protein in patients with cutaneous melanoma

Melanoma Research

Volumn 12, Issue 6, 2002, Pages 627-631

  Brouard, M C ^a   Saurat, J H ^a   Ghanem, G ^b   Siegenthaler, G ^a  

^a Faculty of Medicine   (Switzerland)

^b JULES BORDET INSTITUTE   (Belgium)

Author keywords

Calcium binding proteins; Fatty acids; Melanoma; Urine

Indexed keywords

CHEMOTACTIC PEPTIDE; FATTY ACID BINDING PROTEIN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; KIDNEY CONCENTRATING CAPACITY; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SKIN CARCINOMA; URINALYSIS; URINARY EXCRETION;

EID: 0036941283     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200212000-00013     Document Type: Article

References (23)

1. Masouyé I, Hagens G, Van Kuppevelt T, Madsen P, Saurat J-H, Veerkamp J, et al. Endothelial cells of the human microvasculature express epidermal fatty acid-binding protein. Circ Res 1997; 81: 297-303.
2. Masouye I, Saurat J, Siegenthaler G. Epidermal fatty-acid-binding protein in psoriasis, basal and squamous cell carcinomas: An immunohistological study. Dermatology 1996; 192: 208-213.
3. Newman M. Inhibition of carcinoma and melanoma cell growth by type 1 transforming growth factor β is dependent on the presence of polyunsaturated fatty acids. Proc Natl Acad Sci USA 1990; 87: 5543-5547.
4. Mannini A, Calorini L, Mugnai G, Ruggieri S. Diminution of the development of experimental metastases produced by murine metastatic cell lines in essential fatty acids-deficient host mice. Clin Exp Metastasis 1998; 16: 407-414.
5. Jing C, Beesley C, Foster CS, Chen H, Rudland PS, West DC, et al. Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res 2001; 61: 4357-4364.
6. Brouard M, Quillien V, Ollivier I, Lesimple T, Adamski H, Chevrant-Breton J. Serum S100B protein and stage of cutaneous melanoma: A prospective study. Ann Dermatol Venereol 2000;127: 56-59.
7. Hagens G, Masouyé I, Augsburger E, Hotz R, Saurat J-H, Siegenthaler G. Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes. Biochem J 1999; 339: 419-427.
8. Hagens G, Roulin K, Hotz R, Saurat J-H, Hellman U, Siegenthaler G. Probable interaction between S100A7 and E-FABP in the cytosol of human keratinocytes from psoriatic scales. Mol Cell Biochem 1999; 192: 123-128.
9. Donato R. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33: 637-668.
10. Balch C, Buzaid A, Atkins M, Cascinelli N, Coit D, Fleming I, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 2000; 88: 1484-1491.
11. Siegenthaler G, Hotz R, Chatellard-Gruaz D, Didierjean L, Hellman U, Saurat J-H. Purification and characterization of the human epidermal fatty acid-binding protein: Localization during epidermal cell differentiation in vivo and in vitro. Biochem J 1994; 302: 363-371.
12. Schwartz D. Les petits échantillons. In: Schwartz D, editor. Méthodes Statistiques à l'Usage des Médecins et des Biologistes, 4th Edition. Paris: Flammarion; 1993. pp. 93-100.
13. Kim M, Warren T, Kimball E. Purification and characterization of a low molecular weight transforming growth factor from the urine of melanoma patients. J Biol Chem 1985; 260: 9237-9243.
14. Ellis D, Chow J, King L. Detection of urinary TGF-α by HPLC and western blot in patients with melanoma. J Invest Dermatol 1990; 95: 27-30.
15. Ostergaard M, Wolf H, Orntoft T, Celis J. Psoriasin (S100A7): A putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas. Electrophoresis 1999; 20: 349-354.
16. Long E, Shepherd R. The incidence and significance of vaginal metaplasia of the bladder trigone in adult women. Br J Urol 1983; 55: 189-194.
17. O'Shaughnessy R, Seery J, Celis J, Frischauf AM, Watt F. PA-FABP, a novel marker of human epidermal transit amplifying cells revealed by 2D protein gel electrophoresis and cDNA array hybridisation. FEBS Lett 2000; 486: 149-154.
18. Enerback C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S, et al. Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res 2002; 62: 43-47.
19. Schlagbauer-Wadl H, Griffioen M, van Elsas A, Schrier P, Pustelnik T, Eichler H, et al. Influence of increased cMyc expression on the growth characteristics of human melanoma. J Invest Dermatol 1999; 112: 332-336.
20. Coller H, Grandori C, Tamayo P, Colbert T, Lander E, Eisenman R, et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci USA 2000; 97: 3260-3265.
21. Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, et al. Psoriasin: A novel chemotactic protein. J Invest Dermatol 1996; 107: 5-10.
22. Hofmann M, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97: 889-901.
23. Taguchi A, Blood D, del Toro G, Canet A, Lee D, Qu W, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000; 405: 354-360.